No Data
No Data
Incannex Healthcare Completes Phase 2 Enrollment in RePOSA Phase 2/3 Trial of IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)
Express News | Incannex Healthcare Completes Phase 2 Enrollment in Reposa Phase 2/3 Trial of Ihl-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (Osa)
Incannex Healthcare Files Registration Statement for Sale of Shares
Incannex Healthcare Repays Convertible Debenture in Full
The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.
Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.
New York Manufacturing Hits Low, Inflation Fears Rise